Appeal No. 1997-1383
Application No. 08/217,392
Group 1-- claims 1, 2, 4, 8(1), 9(1), 12(1), 24(1), 29(1),
30(1), 31(1), 33(1), 34, 35, 37, 41-45, 57, 62-64
and 66.
Group 2-- claims 5, 12(5), 24(5), 29(5), 30(5), 31(5) and
33(5).
Group 3-- claims 3, 6, 8(5), 9(5) and 36.
Group 4-- claims 27(1) and 60.
Group 5-- claims 17(1), 28(1), 50 and 61.
Group 6-- claims 32(1) and 65.
Group 7-- claim 27(5).
Group 8-- claims 17(5) and 28(5).
Group 9-- claim 32(5).
Group 10-- claims 67 and 70.
Group 11-- claim 68.
Group 12-- claim 69.
Group 13-- claim 71.
As a further note, we will only address Appellants’
arguments of record. We are not required to raise and/or
consider other issues. As stated by our reviewing court in In
re Baxter Travenol Labs., 952 F.2d 388, 391, 21 USPQ2d 1281,
5
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007